Products for Research Use Only
RegisterLogin

CDK2-IN-13

CAT: 0804-HY-W478102-01Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W478102-01Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK2-IN-13 (Compound 15) is a CDK2 inhibitor with an IC50 of 12 µM. CDK2-IN-13 can be used in research of cancer[1].
CAS Number
101622-53-1
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk2-in-13.html
Purity
98.20
Solubility
DMSO : 11.11 mg/mL (ultrasonic; warming; adjust pH to 11 with NaOH; heat to 60°C)
Smiles
CN1C=NC2=C(N=C(N=C21)Cl)NCC3=CC=CC=C3
Molecular Formula
C13H12ClN5
Molecular Weight
273.73
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]Havlícek L, et al. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem. 1997 Feb 14;40 (4) :408-12.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P0235CDK2
HY-134622-01GSK-3/CDK5/CDK2-IN-1
HY-139980-01CDK9-IN-13
HY-149974-01CDK8-IN-13
HY-147597CDK7-IN-13
HY-117535-01CDK2-IN-4
HY-157516-01CDK2-IN-22
HY-139651CDK2-IN-7
HY-144810CDK2-IN-8
HY-179231CDK2-IN-50

Alternative Products

CatalogName
BA3863-100CDK2-IN-13
S0B0819-01CDK2 Recombinant Rabbit mAb (S-1308-13)
C07088-100mgCDK2-IN-73 (CDK2-IN-4)
521331-01CDK2

Popular Products